Hasil Pencarian - Heribert Staudinger

  • Menampilkan 1 - 3 hasil dari 3
Perbaiki Hasil
  1. 1
    A first‐in‐human, single and multiple dose study of lunsekimig, a novel anti‐TSLP/anti‐IL‐13 NANOBODY® compound, in healthy volunteers

    A first‐in‐human, single and multiple dose study of lunsekimig, a novel anti‐TSLP/anti‐IL‐13 NANOBODY® compound, in healthy volunteers oleh Annemie Deiteren, Lieselot Bontinck, Griet Conickx, Marie Vigan, Nele Dervaux, Matthieu Gassiot, Selcuk Bas, Benjamin Suratt, Heribert Staudinger, Emmanuel Krupka

    Diterbitkan 2024-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    Immunomodulatory and clinical effects of receptor-interacting protein kinase 1 (RIPK1) inhibitor eclitasertib (SAR443122) in patients with severe COVID-19: a phase 1b, randomized, double-blinded, placebo-controlled study

    Immunomodulatory and clinical effects of receptor-interacting protein kinase 1 (RIPK1) inhibitor eclitasertib (SAR443122) in patients with severe COVID-19: a phase 1b, randomized,... oleh Pierre-Francois Clot, Christine Farenc, Benjamin T. Suratt, Tillmann Krahnke, Agnes Tardat, Peter Florian, Robert Pomponio, Naimish Patel, Maria Wiekowski, Yong Lin, Benjamin Terrier, Heribert Staudinger

    Diterbitkan 2024-02-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    Dupilumab Improves Upper and Lower Airway Outcome Measures in Patients With CRSwNP With NSAID-ERD: Pooled Results from the SINUS-24 and SINUS-52 Phase 3 Trials

    Dupilumab Improves Upper and Lower Airway Outcome Measures in Patients With CRSwNP With NSAID-ERD: Pooled Results from the SINUS-24 and SINUS-52 Phase 3 Trials oleh Tanya M. Lailaw, Mullol Joaquim, Walter Canonica, Claus Bachert, Joseph K. Han, Mei Zhang, Xin Lu, Naimish Patel, Neil M.H. Graham, Heribert Staudinger, Leda P. Mannent, Nikhil Amin

    Diterbitkan 2020-08-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: